MRK logo

MRK
Merck & Co Inc

25,761
Mkt Cap
$277.02B
Volume
11.95M
52W High
$125.14
52W Low
$73.31
PE Ratio
31.57
MRK Fundamentals
Price
$112.16
Prev Close
$109.18
Open
$112.33
50D MA
$117.53
Beta
0.31
Avg. Volume
9.33M
EPS (Annual)
$7.28
P/B
5.28
Rev/Employee
$865,680.00
$299,786.82
Loading...
Loading...
News
all
press releases
PFA Pension Forsikringsaktieselskab Makes New Investment in Merck & Co., Inc. $MRK
PFA Pension Forsikringsaktieselskab purchased a new position in Merck & Co., Inc. (NYSE:MRK - Free Report) in the 4th quarter, according to the company in its most recent 13F filing with the...
MarketBeat·4h ago
News Placeholder
More News
News Placeholder
Sigma Planning Corp Acquires 10,367 Shares of Merck & Co., Inc. $MRK
Sigma Planning Corp grew its holdings in Merck & Co., Inc. (NYSE:MRK - Free Report) by 28.3% in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 46,968 shares of the company's stock after acquiring an additional 10,367 shares durin...
MarketBeat·5h ago
News Placeholder
Merck & Co., Inc. Q1 Earnings Call Highlights
Merck & Co., Inc. (NYSE:MRK) reported first-quarter 2026 revenue of $16.3 billion, up 5% year over year, as the company highlighted continued oncology momentum, growing contributions from newer launches, and a series of regulatory and pipeline milestones discussed on its quarterly sales and earn...
MarketBeat·13h ago
News Placeholder
Should You Buy, Hold, or Sell GILD Stock Ahead of Q1 Earnings?
Gilead Sciences gears up for Q1 earnings with HIV drugs driving growth, but cell therapy headwinds and rising costs could shape the outlook.
Zacks·22h ago
News Placeholder
Moderna Reports Q1 Loss, Stock Jumps on Strong International Sales
MRNA narrows Q1 loss and beats revenue estimates as international vaccine sales surge, lifting shares despite hefty litigation charges.
Zacks·1d ago
News Placeholder
Merck & Co., Inc. (NYSE:MRK) Price Target Cut to $145.00 by Analysts at Wells Fargo & Company
Wells Fargo & Company dropped their target price on Merck & Co., Inc. from $150.00 to $145.00 and set an "overweight" rating for the company in a research note on Friday...
MarketBeat·1d ago
News Placeholder
Oppenheimer Asset Management Inc. Sells 51,113 Shares of Merck & Co., Inc. $MRK
Oppenheimer Asset Management Inc. decreased its stake in shares of Merck & Co., Inc. (NYSE:MRK - Free Report) by 9.2% during the fourth quarter, according to its most recent filing with the...
MarketBeat·1d ago
News Placeholder
Fifth Third Bancorp Lowers Position in Merck & Co., Inc. $MRK
Fifth Third Bancorp decreased its stake in shares of Merck & Co., Inc. (NYSE:MRK - Free Report) by 1.9% in the 4th quarter, according to its most recent Form 13F filing with the SEC. The fund owned...
MarketBeat·1d ago
News Placeholder
Danica Pension Livsforsikringsaktieselskab Purchases 56,400 Shares of Merck & Co., Inc. $MRK
Danica Pension Livsforsikringsaktieselskab raised its position in Merck & Co., Inc. (NYSE:MRK - Free Report) by 41.6% during the 4th quarter, according to its most recent filing with the SEC. The...
MarketBeat·1d ago
News Placeholder
Danske Bank A S Has $196.36 Million Stock Holdings in Merck & Co., Inc. $MRK
Danske Bank A S decreased its stake in Merck & Co., Inc. (NYSE:MRK - Free Report) by 2.1% in the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange...
MarketBeat·1d ago
<
1
2
...
>

Latest MRK News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.